{"text": "rt AT_USER #fda\u00a1\u00afs #aac votes 12-1 against recommending approval of $jnj\u00a1\u00afs sirukumab."}
{"text": "$jnj: johnson &amp; johnson announces that the arthritis advisory committee of the fda did not recommend approval of... URL"}
{"text": "hey, do you know everything while trading #sp500? $goog $jnj $ge URL URL"}
{"text": "rt AT_USER abbvie, part 2: its strengths beyond humira, and weakness URL $agn $celg $gild $incy $jnj $lly $nbi\u00a1\u00ad"}
{"text": "fda panel votes against approval of j&amp;j arthritis drug $jnj  URL"}
{"text": "rt AT_USER sirukumab fails fda adcomm with final 1y:11n vote on approval. $jnj"}
{"text": "$jnj u.s. fda panel votes against approval of j&amp;j arthritis drug URL"}
{"text": "rt AT_USER #fda\u00a1\u00afs #aac votes 12-1 against recommending approval of $jnj\u00a1\u00afs sirukumab."}
{"text": "rt AT_USER AT_USER #aap vote: is safety profile for $jnj's sirukumab adequate? y - 2, n \u00a8c 11"}
{"text": "rt AT_USER sirukumab fails fda adcomm with final 1y:11n vote on approval. $jnj"}
{"text": "rt AT_USER commented on pfizer: why the stock may get interesting again URL $azn $bmy $jnj $teva $zts $biib $ce\u00a1\u00ad"}
{"text": "$jnj u.s. fda panel votes against approval of j&amp;j arthritis drug URL"}
{"text": "commented on pfizer: why the stock may get interesting again URL $azn $bmy $jnj $teva $zts $biib $celg $gild $pfe"}
{"text": "salphatrending: pfizer: why the stock may get interesting again URL $azn $bmy $jnj $teva $zts $biib $celg $gild $pfe"}
{"text": "pfizer: why the stock may get interesting again URL $azn $bmy $jnj $teva $zts $biib $celg $gild $pfe"}
{"text": "$jnj valuation is expensive, ev/ebitda is at 10-year highs #stocks #valueinvesting #stockmarket URL"}
{"text": "rt AT_USER #fda\u00a1\u00afs #aac votes 12-1 against recommending approval of $jnj\u00a1\u00afs sirukumab."}
{"text": "j&amp;j's diabetes med invokana trumps lilly and bi's jardiance on cvs p... $jnj $cvs $lly $mrk $teva $biib $pfe URL"}
{"text": "ad com approaches for j&amp;j's ra candidate sirukumab $jnj URL"}
{"text": "rt AT_USER pharmalot.. pharmalittle.. good morning.. hot headlines and coffee are finally served.. URL #pharma $jnj\u00a1\u00ad"}
{"text": "sirukumab fails fda adcomm with final 1y:11n vote on approval. $jnj"}
{"text": "$jnj fda arthritis advisory committee votes 12-1 against recommending approval for sirukumab injection for the tre\u00a1\u00ad URL"}
{"text": "rt AT_USER AT_USER #aap vote: is safety profile for $jnj's sirukumab adequate? y - 2, n \u00a8c 11"}
{"text": "#fda\u00a1\u00afs #aac votes 12-1 against recommending approval of $jnj\u00a1\u00afs sirukumab."}
{"text": "rt AT_USER AT_USER #aap vote: is safety profile for $jnj's sirukumab adequate? y - 2, n \u00a8c 11"}
{"text": "pfizer: why the stock may get interesting again URL $azn $bmy $jnj $teva $zts $biib $celg $gild $pfe"}
{"text": "rt AT_USER AT_USER #aap vote: is safety profile for $jnj's sirukumab adequate? y - 2, n \u00a8c 11"}
{"text": "rt AT_USER in 13-0, AT_USER #aap finds substantial evidence of efficacy for $jnj's sirukumab in rheumatoid arthritis"}
{"text": "rt AT_USER pfizer: why the stock may get interesting again URL $azn $bmy $jnj $teva $zts $biib $celg $gild $pfe"}
{"text": "rt AT_USER AT_USER #aap vote: is safety profile for $jnj's sirukumab adequate? y - 2, n \u00a8c 11"}
{"text": "rt seekingalpha \"pfizer: why the stock may get interesting again URL $azn $bmy $jnj $teva $zts $biib $celg $gild $pfe"}
{"text": "pfizer: why the stock may get interesting again URL $azn $bmy $jnj $teva $zts $biib $celg $gild $pfe"}
{"text": "fda ad com backs efficacy of j&amp;j's sirukumab in rheumatoid arthritis but thumbs down on safety profile URL $jnj $gsk"}
{"text": "fda ad com backs efficacy of j&amp;j's sirukumab in rheumatoid arthritis but thumbs down on safety profile URL $jnj $gsk"}
{"text": "rt AT_USER vote: is the safety profile of sirukumab adequate to support approval for the proposed rheumatoid arthritis indication? $jnj\u00a1\u00ad"}
{"text": "...and one of the \"yes\" votes says he intended to vote no - $jnj"}
{"text": "rt AT_USER vote: is the safety profile of sirukumab adequate to support approval for the proposed rheumatoid arthritis indication? $jnj\u00a1\u00ad"}
{"text": "rt AT_USER vote: is the safety profile of sirukumab adequate to support approval for the proposed rheumatoid arthritis indication? $jnj\u00a1\u00ad"}
{"text": "rt AT_USER vote: is the safety profile of sirukumab adequate to support approval for the proposed rheumatoid arthritis indication? $jnj\u00a1\u00ad"}
{"text": "rt AT_USER vote: do the data provide substantial evidence of efficacy of #sirukumab for the proposed rheumatoid arthritis indication? $\u00a1\u00ad"}
{"text": "rt AT_USER vote: is the safety profile of sirukumab adequate to support approval for the proposed rheumatoid arthritis indication? $jnj\u00a1\u00ad"}
{"text": "rt AT_USER vote: do the data provide substantial evidence of efficacy of #sirukumab for the proposed rheumatoid arthritis indication? $\u00a1\u00ad"}
{"text": "AT_USER #aap vote: is safety profile for $jnj's sirukumab adequate? y - 2, n \u00a8c 11"}
{"text": "rt investingbuddy \"take a look deeper beneath jnjnews q2 #earnings in this #stocks #fundamentalanalysis of $jnj by\u00a1\u00ad URL"}
{"text": "take a look deeper beneath AT_USER q2 #earnings in this #stocks #fundamentalanalysis of $jnj by AT_USER  &gt;&gt;&gt;\u00a1\u00ad URL"}
{"text": "take a look deeper beneath AT_USER q2 #earnings in this #stocks #fundamentalanalysis of $jnj by AT_USER  &gt;&gt;&gt;\u00a1\u00ad URL"}
{"text": "take a look deeper beneath AT_USER q2 #earnings in this #stocks #fundamentalanalysis of $jnj by AT_USER  &gt;&gt;&gt;\u00a1\u00ad URL"}
{"text": "take a look deeper beneath AT_USER q2 #earnings in this #stocks #fundamentalanalysis of $jnj by AT_USER  &gt;&gt;&gt;\u00a1\u00ad URL"}
{"text": "take a look deeper beneath AT_USER q2 #earnings in this #stocks #fundamentalanalysis of $jnj by AT_USER  &gt;&gt;&gt;\u00a1\u00ad URL"}
{"text": "take a look deeper beneath AT_USER q2 #earnings in this #stocks #fundamentalanalysis of $jnj by AT_USER  &gt;&gt;&gt;\u00a1\u00ad URL"}
{"text": "anybody detecting the direction of the wind on the safety discussion? not good for $jnj"}
{"text": "rt AT_USER in 13-0, AT_USER #aap finds substantial evidence of efficacy for $jnj's sirukumab in rheumatoid arthritis"}
{"text": "rt AT_USER vote: do the data provide substantial evidence of efficacy of #sirukumab for the proposed rheumatoid arthritis indication? $\u00a1\u00ad"}
{"text": "rt AT_USER vote: do the data provide substantial evidence of efficacy of #sirukumab for the proposed rheumatoid arthritis indication? $\u00a1\u00ad"}
{"text": "rt AT_USER vote: do the data provide substantial evidence of efficacy of #sirukumab for the proposed rheumatoid arthritis indication? $\u00a1\u00ad"}
{"text": "rt AT_USER in 13-0, AT_USER #aap finds substantial evidence of efficacy for $jnj's sirukumab in rheumatoid arthritis"}
{"text": "cypress capital management has increased by $1.22 million its johnson &amp; johnson $jnj stake ..."}
{"text": "$gild consolidating this week. $abbv $mrk $jnj 80% of hcv ms. 70% of hiv ms."}
{"text": "in 13-0, AT_USER #aap finds substantial evidence of efficacy for $jnj's sirukumab in rheumatoid arthritis"}
{"text": "$jnj latest press releases #fda URL"}
{"text": "here are the questions (2 of 2) $jnj #sirukumab. also fda notes that 1 would vote yes on 2 and 6 to be consistent w\u00a1\u00ad URL"}
{"text": "here are the questions (1 of 2) $jnj #sirukumab URL"}
{"text": "rt AT_USER #ai #ml #iot #robotics to usher revolution in #oncology URL $goog $msft $ibm $jnj $pfe $nvs $gsk $sny $m\u00a1\u00ad"}
{"text": "rt AT_USER #ai #ml #iot #robotics to usher revolution in #oncology URL $goog $msft $ibm $jnj $pfe $nvs $gsk $sny $m\u00a1\u00ad"}
{"text": "here's where we're at with the #sirukumab fda adcomm.  member also noted 16 ra drugs overall (1st and 2nd line).\u00a1\u00ad URL"}
{"text": "few fireworks at AT_USER #aap mtg on $jnj's sirukumab for ra; numerical imbalance in all-cause mortality has been main focus so far"}
{"text": "AT_USER fda raises big safety concerns with johnson &amp; johnson $jnj's arthritis drug sirukumab\u00a1\u00ad URL"}
{"text": "pioneer trust bank n a has lowered its holding in johnson &amp; johnson com $jnj by $351,325 as market value rose ..."}
{"text": ".AT_USER AT_USER wooohooo... as if $jnj products aren't already causing enough suffering and death URL"}
{"text": "johnson &amp; johnson $jnj shares bought by headinvest llc URL"}
{"text": ".AT_USER AT_USER wooohooo... as if $jnj products aren't already causing enough suffering and death URL"}
{"text": ".AT_USER AT_USER wooohooo... as if $jnj products aren't already causing enough suffering and death URL"}
{"text": ".AT_USER AT_USER wooohooo... as if $jnj products aren't already causing enough suffering and death URL"}
{"text": "$jnj abbvie/johhnson &amp; johnson receive expanded fda approval of imbruvica for the treatment of adult patients with\u00a1\u00ad URL"}
{"text": "johnson &amp; johnson $jnj stake increased by grimes &amp; company inc. URL"}
{"text": ".AT_USER AT_USER wooohooo... as if $jnj products aren't already causing enough suffering and death URL"}
{"text": "johnson &amp; johnson $jnj stake increased by grimes &amp; company inc. URL"}
{"text": ".AT_USER AT_USER wooohooo... as if $jnj products aren't already causing enough suffering and death URL"}
{"text": "and here's yet more btk news, with first non-oncology approval for imbruvica $abbv $jnj URL"}
{"text": "s&amp;p100 #stocks performance $gd $amgn $msft $nee $rtn $bmy $celg $cat $fdx $jnj $pcln $mdt $dis $agn $intc  more@ URL"}
{"text": "j&amp;j's diabetes med invokana trumps lilly and bi's jardiance on cvs preferred list URL $jnj $cvs $lly $mrk"}
{"text": "j&amp;j's diabetes med invokana trumps lilly and bi's jardiance on cvs preferred list URL $jnj $cvs $lly $mrk"}
{"text": "first citizens bank &amp; trust co trimmed by $5.50 million its johnson &amp; johnson $jnj stake ..."}
{"text": "fda summary slides on gi perforation, lab abnormalities and safety $jnj #sirukumab URL"}
{"text": "fda summary  slides on saes, mace, infection and malignancy $jnj #sirukumab URL"}
{"text": "fda slides on all cause death in #sirukumab ra program $jnj.how to interpret the imbalance seen in period after cro\u00a1\u00ad URL"}
{"text": "l &amp; s advisors has lowered johnson &amp; johnson $jnj stake by $3.07 million as shares rose ..."}
{"text": ".AT_USER AT_USER wooohooo... as if $jnj products aren't already causing enough suffering and death URL"}
{"text": "fda overall efficacy findings $jnj #sirukumab URL"}
{"text": "#pharmastocks #traders look at what $jnj q2 #earnings really mean in quick fundamentals report by AT_USER here&gt;\u00a1\u00ad URL"}
{"text": "the hematologist 2017 AT_USER year's best highlights $jnj darzalex-has much longer time savings w $halo enhanze than\u00a1\u00ad URL"}
{"text": "fda on efficacy and safety in ph2 dose-ranging trials. fda tells panel they'll ask for input on $jnj final dose sel\u00a1\u00ad URL"}
{"text": "rt AT_USER if sirukumab is approved, $jnj committed to postmarket safety study and enhanced pharmacovigilance. #aac"}
{"text": "rt AT_USER $jnj\u00a1\u00afs yeilding concludes that although can\u00a1\u00aft exclude possibility of mortality difference, sirukumab has acceptable safety pr\u00a1\u00ad"}
{"text": "rt AT_USER $jnj attributes mortality imbalance seen in sirukumab trials to crossover design. #aac"}
{"text": "in another trial of absolute insanity, $jnj testing drug with increased #infections, #cancer and #death to 'treat' depression!"}
{"text": "retirement, for people in a hurry URL $arcc $cldt $ctl $din $ed $epr $geo $gov $jnj $main $mo $msft $o $ohi $rai $rmr"}
{"text": "salphatrending: abbvie, part 2: its strengths beyond humira, and weakness URL $agn $celg $gild $incy $jnj $lly $nbix $\u00a1\u00ad"}
{"text": "canandaigua national bank &amp; trust company increased johnson &amp; johnson $jnj position by $348,795 as share va..."}
{"text": "a great total return company but quality does not come cheap URL $amt $ba $dlr $hd $hog $jnj $mo $ohi $txn $msft"}
